SRC and systemic lupus erythematosus: Of interest, FGR, a member of the Src family of protein tyrosine kinases (PTKs) was scoring high for being a drug target for non-SLE conditions, but in close PPI connections with SLE validated targets, making it a potential candidate for drug repositioning.